Answers are grounded in this paper and cite their sources.
A VIEW FROM TWO SIDES I write this editorial from an unusual vantage point. My clinical formation began in India, where Oral Medicine and Radiology (OMR) is practiced and taught as a single integrated specialty one discipline that holds imaging, mucosal diagnosis, oral oncology, and systemic medicine in the same intellectual framework, in the same clinician. My career later transitioned to the United States, where those domains have been separated into distinct specialties: Oral Medicine on one side, Oral and Maxillofacial Radiology on the other. Having recently completed a term as President of the American Academy of Oral Medicine, I have spent considerable time thinking about what each system loses by not having what the other takes for granted. That structural difference is not merely academic. It is, I would argue, a microcosm of the larger problem this editorial addresses. The very data, clinical reasoning, and biological insight that precision health demands us to integrate imaging phenotypes, mucosal biology, salivary signatures, systemic risk, and oncologic follow-up is being fragmented at the level of specialty architecture itself. If we cannot hold these together within a single clinical discipline, we should not be surprised that we cannot hold them together within a single data ecosystem. THE CONVERGENCE WE CANNOT YET FULLY SEE OMR is entering a period of genuine complexity, not the productive complexity of technical progress, but the harder kind: where the direction of change is clear, the stakes are high, and the field’s current architecture is not built for what is coming. The convergence of advanced imaging, multiomics, and artificial intelligence is already demonstrating improvements in diagnostic accuracy, reduced diagnostic error, and accelerated clinical workflows including virtual care in precision health.[1–4] But these advances are not arriving in a coordinated, clinically governed way. They are arriving as fragments, the concept of radiomics, salivary proteomics, AI triage tool, virtual care followed by regulatory governance, advocacy and licensing add complexity to fragmented system.[5,6] The central problem is not the absence of innovation. It is the absence of an integrative framework that can hold these pieces together responsibly, equitably, and in a form that actually reaches patients. OMR sits at the convergence of imaging, biology, clinical history, and systemic risk. That position is not incidental it is architecturally significant. But it also means that OMR is the specialty most exposed to the consequences of multimodal fragmentation overload. WHY IS THIS HARDER THAN IT LOOKS Consider what true precision care in oral oncology would require. A clinician evaluating a potentially malignant oral lesion in a Tier-III city would need, not only tissue sample, but salivary biomarker data, a validated AI triage output, a cloud-based second opinion from a specialist, and a longitudinal follow-up protocol that works without a full hospital infrastructure. If the lesion is poitive for malignancy, a follow up with imaging studies and oncologic workup becomes necessary. Each of those components exists, in some form, somewhere. None of them are interoperable. Individual clinical components may be internally standardized; what does not yet exist is any agreed protocol for how they are sequenced within multimodal AI analytic pathways, calibrated against each other, or governed at the point of clinical decision. The conceptual possibility of a “bio-digital twin”, a composite model linking a patient’s anatomical imaging, salivary signatures, tobacco exposure, metabolic status, and longitudinal follow-up history into a unified clinical decision layer is increasingly within reach. But possibility is not proximity. The problems of data provenance, interoperability, consent architecture, validation across diverse demographic cohorts, and meaningful human oversight at the point of clinical decision remain substantially unsolved. These are not purely technical problems awaiting a software solution; they are governance problems awaiting clinical leadership. The challenge is fundamentally one of fragmented systems operating under fragmented governance. India faces a dual burden: A disproportionately high prevalence of oral potential malignant disorder (OPMD) and oral cancer with India accounting for more than one-third of the global oral cancer burden and approximately 130,000 new cases and a mortality toll exceeding 75,000 in 2020[7] alone concentrated in populations with limited specialist access, alongside profound unevenness in care infrastructure across metropolitan, suburban, and rural settings.[8] The United States presents a different configuration of the same problem one that the rest of the world watches closely precisely because its governance frameworks set de facto global standards. Health Insurance Portability and Accountability Act (HIPAA) compliance, Food and Drug Administration (FDA) clearance pathways for AI-enabled diagnostics, state-by-state licensure constraints, and a structurally bifurcated insurance system where medical and dental coverage operate as separate silos with no reimbursement pathway for emerging diagnostics, together create friction does not yet face in the same form but will.[9] In both systems, the interoperability problem does not disappear; it simply wears different institutional clothing. And the more honest acknowledgment is this: The data layer itself the question of who owns, standardizes, curates, and governs the convergent data stream in oral medicine has not been seriously addressed in any system, anywhere. This is a collective failure of governance that crosses national boundaries and health system models alike. Whether the context is a Tier-III district in India, a rural county in the United States, a regional health trust in the United Kingdom, or a public health network in Australasia, the same structural absence presents itself: rich, clinically distinctive oral medicine data being generated without the architecture to make it interoperable, accountable, or cumulatively useful. A FOUNDATION THAT ALREADY EXISTS The diagnostic breadth, the oral oncology experience, the mucosal surveillance expertise, and the imaging-biology interface embedded in OMR training represent a foundation of clinical competency that most precision health frameworks are attempting to approximate from the outside. OMR, recognized and practiced as an integrated specialty long before these competencies were separated from general dentistry in other parts of the world, carries deeper clinical architecture for this work than is commonly acknowledged in global health informatics and administrative conversations. What the specialty has not yet fully leveraged is the strategic infrastructure to translate that clinical depth into a governed, interoperable data ecosystem. This is not merely an academic gap. It is a strategic one with consequences that compound over time. Other clinical care domains such as cardiology, oncology, genomics, etc., are already building proprietary and consortium-based data architectures, defining the ontologies and governance models that will shape how patient data flows through health systems for the next generation3. The specialty that has the deepest custodianship over oral medicine/oral oncology data that sits at the intersection of imaging, mucosal biology, oral oncologic surveillance, and systemic risk has a global responsibility that has not yet been matched by global coordination. The gap is worth closing and closing deliberately, before the architecture is built around us rather than by us. THE INTERFACES WE CANNOT AFFORD TO IGNORE The scope of integration extends beyond the imaging-biology axis. Panoramic radiographs carry information about carotid artery calcification, mandibular cortical density, and skeletal risk that currently goes systematically unreported outside of specialist settings.[10,11] Virtual surgical planning for orthognathic and maxillofacial procedures depends on the same imaging data that OMR curates with systematic review evidence demonstrating significant improvements in surgical accuracy and planning outcomes compared to conventional methods.[12,13] The oral-systemic interface the relationship between oral inflammation, metabolic disease, cardiovascular risk, and immune status is a scientific frontier with a robust and growing evidence base, supported by clinical practice guidelines that reflect the specialty’s depth and rigor.[14] What has not kept pace is the informatics and administrative infrastructure needed to translate that clinical standing into interoperable data systems, AI integration, cross-specialty referral pathways, and reimbursement frameworks that reflect the full scope of what oral medicine contributes to systemic health.[15] Each of these interfaces represents both a clinical opportunity and a governance question that has not yet been answered. They are the operational problems that determine whether precision OMR functions as a coherent clinical system or as an impressive but disconnected collection of tools. A NOTE TO CLOSE: THE BENCH CANNOT WAIT FOR THE BYTE TO CATCH UP ON ITS OWN This editorial is not a roadmap. It is, honestly, an invitation, and a candid acknowledgment that the problems described here exceed what any single specialty body, institution, or research group can resolve independently. What is needed is structured global collaboration between clinical specialists, data scientists, health equity researchers, and interdisciplinary, interprofessional teams and with appropriate governance and transparency, integrated technology and investment partners who share a long-term stake in building infrastructure that serves patients rather than platforms. The coordination that global precision oral medicine requires will not emerge from any single regulatory body or technology platform. It will require the clinical community itself to define the terms before others define them on our behalf. The bench and the byte need each other. So do we.
No takes yet. Share an insight, caveat, or question.
Jaisri R. Thoppay (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: